440 related articles for article (PubMed ID: 25452729)
1. Does the kappa opioid receptor system contribute to pain aversion?
Cahill CM; Taylor AM; Cook C; Ong E; Morón JA; Evans CJ
Front Pharmacol; 2014; 5():253. PubMed ID: 25452729
[TBL] [Abstract][Full Text] [Related]
2. Role of the Dynorphin/Kappa Opioid Receptor System in the Motivational Effects of Ethanol.
Anderson RI; Becker HC
Alcohol Clin Exp Res; 2017 Aug; 41(8):1402-1418. PubMed ID: 28425121
[TBL] [Abstract][Full Text] [Related]
3. Kappa Opioid Receptors Drive a Tonic Aversive Component of Chronic Pain.
Liu SS; Pickens S; Burma NE; Ibarra-Lecue I; Yang H; Xue L; Cook C; Hakimian JK; Severino AL; Lueptow L; Komarek K; Taylor AMW; Olmstead MC; Carroll FI; Bass CE; Andrews AM; Walwyn W; Trang T; Evans CJ; Leslie FM; Cahill CM
J Neurosci; 2019 May; 39(21):4162-4178. PubMed ID: 30862664
[TBL] [Abstract][Full Text] [Related]
4. Kappa Opioid Signaling at the Crossroads of Chronic Pain and Opioid Addiction.
Cahill CM; Lueptow L; Kim H; Shusharla R; Bishop A; Evans CJ
Handb Exp Pharmacol; 2022; 271():315-350. PubMed ID: 33547588
[TBL] [Abstract][Full Text] [Related]
5. Sex Differences in Kappa Opioid Receptor Function and Their Potential Impact on Addiction.
Chartoff EH; Mavrikaki M
Front Neurosci; 2015; 9():466. PubMed ID: 26733781
[TBL] [Abstract][Full Text] [Related]
6. The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system.
Land BB; Bruchas MR; Lemos JC; Xu M; Melief EJ; Chavkin C
J Neurosci; 2008 Jan; 28(2):407-14. PubMed ID: 18184783
[TBL] [Abstract][Full Text] [Related]
7. Relative Timing Between Kappa Opioid Receptor Activation and Cocaine Determines the Impact on Reward and Dopamine Release.
Chartoff EH; Ebner SR; Sparrow A; Potter D; Baker PM; Ragozzino ME; Roitman MF
Neuropsychopharmacology; 2016 Mar; 41(4):989-1002. PubMed ID: 26239494
[TBL] [Abstract][Full Text] [Related]
8. Estrogen Regulation of GRK2 Inactivates Kappa Opioid Receptor Signaling Mediating Analgesia, But Not Aversion.
Abraham AD; Schattauer SS; Reichard KL; Cohen JH; Fontaine HM; Song AJ; Johnson SD; Land BB; Chavkin C
J Neurosci; 2018 Sep; 38(37):8031-8043. PubMed ID: 30076211
[TBL] [Abstract][Full Text] [Related]
9. Neuropathic pain activates the endogenous kappa opioid system in mouse spinal cord and induces opioid receptor tolerance.
Xu M; Petraschka M; McLaughlin JP; Westenbroek RE; Caron MG; Lefkowitz RJ; Czyzyk TA; Pintar JE; Terman GW; Chavkin C
J Neurosci; 2004 May; 24(19):4576-84. PubMed ID: 15140929
[TBL] [Abstract][Full Text] [Related]
10. Dopaminergic cellular and circuit contributions to kappa opioid receptor mediated aversion.
Margolis EB; Karkhanis AN
Neurochem Int; 2019 Oct; 129():104504. PubMed ID: 31301327
[TBL] [Abstract][Full Text] [Related]
11. Chronic pain recruits hypothalamic dynorphin/kappa opioid receptor signalling to promote wakefulness and vigilance.
Ito H; Navratilova E; Vagnerova B; Watanabe M; Kopruszinski C; Moreira de Souza LH; Yue X; Ikegami D; Moutal A; Patwardhan A; Khanna R; Yamazaki M; Guerrero M; Rosen H; Roberts E; Neugebauer V; Dodick DW; Porreca F
Brain; 2023 Mar; 146(3):1186-1199. PubMed ID: 35485490
[TBL] [Abstract][Full Text] [Related]
12. Traumatic Stress-Induced Vulnerability to Addiction: Critical Role of the Dynorphin/Kappa Opioid Receptor System.
Leconte C; Mongeau R; Noble F
Front Pharmacol; 2022; 13():856672. PubMed ID: 35571111
[TBL] [Abstract][Full Text] [Related]
13. A review of the kappa opioid receptor system in opioid use.
Cayir S; Zhornitsky S; Barzegary A; Sotomayor-Carreño E; Sarfo-Ansah W; Funaro MC; Matuskey D; Angarita G
Neurosci Biobehav Rev; 2024 Jul; 162():105713. PubMed ID: 38733895
[TBL] [Abstract][Full Text] [Related]
14. KOR Control over Addiction Processing: An Exploration of the Mesolimbic Dopamine Pathway.
Estave PM; Spodnick MB; Karkhanis AN
Handb Exp Pharmacol; 2022; 271():351-377. PubMed ID: 33301050
[TBL] [Abstract][Full Text] [Related]
15. Maladaptive behavioral regulation in alcohol dependence: Role of kappa-opioid receptors in the bed nucleus of the stria terminalis.
Erikson CM; Wei G; Walker BM
Neuropharmacology; 2018 Sep; 140():162-173. PubMed ID: 30075159
[TBL] [Abstract][Full Text] [Related]
16. Involvement of the dynorphin/KOR system on the nociceptive, emotional and cognitive manifestations of joint pain in mice.
Negrete R; García Gutiérrez MS; Manzanares J; Maldonado R
Neuropharmacology; 2017 Apr; 116():315-327. PubMed ID: 27567942
[TBL] [Abstract][Full Text] [Related]
17. The Therapeutic Potential of Novel Kappa Opioid Receptor-based Treatments.
Mercadante S; Romualdi P
Curr Med Chem; 2020; 27(12):2012-2020. PubMed ID: 30666905
[TBL] [Abstract][Full Text] [Related]
18. Stress-Induced Reinstatement of Nicotine Preference Requires Dynorphin/Kappa Opioid Activity in the Basolateral Amygdala.
Nygard SK; Hourguettes NJ; Sobczak GG; Carlezon WA; Bruchas MR
J Neurosci; 2016 Sep; 36(38):9937-48. PubMed ID: 27656031
[TBL] [Abstract][Full Text] [Related]
19. Dynorphin, stress, and depression.
Knoll AT; Carlezon WA
Brain Res; 2010 Feb; 1314():56-73. PubMed ID: 19782055
[TBL] [Abstract][Full Text] [Related]
20. The Kappa Opioid Receptor: A Promising Therapeutic Target for Multiple Pathologies.
Dalefield ML; Scouller B; Bibi R; Kivell BM
Front Pharmacol; 2022; 13():837671. PubMed ID: 35795569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
